☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Alphyn Biologics
Alphyn Biologics Reports Interim Results from P-IIa Clinical Trial of AB-101a for Atopic Dermatitis with Secondary Bacterial Infec...
July 17, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.